NCT03437057View on ClinicalTrials.gov

Maintenance of an Antiaggregation by Acetylsalicylic Acid, While a Extracorporeal Lithotripsy Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study

NARecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Renal LithiasisAntiplateletHematoma

Interventions

OTHER

acetylsalicylic acid (below or equal to) 250 mg

Prospective single-arm study to estimate the risk of renal hematoma when performing a session of lithotripsy for renal lithiasis, on a 15-day scanner, in patients treated with acetylsalicylic acid not suspended.

Trial Locations (1)

63003

RECRUITING

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors

lead

University Hospital, Clermont-Ferrand

OTHER